more people with improvements in the demographic and geographic spread of care.
He picked up Ms Stocking's point about the timing of assessments: 'It's always too early for evaluation, until suddenly it's too late'. He also touched on her discussion of predictions, noting that 'the future is no longer what it used to be'. The Dutch Steering Committee of Future Health Scenarios aims to describe policy options rather than straightforwardly forecasting the future.
Evaluations so far completed include heart, liver and bone marrow transplants, in vivo fertilization and coronary by-passes.
The first question from the floor concerned the consumer's view of evaluation, citing the inadequate social and psychological support offered at time of transplant. Dr Bos replied that several countries hold consensus conferences which can deal with this topic, although such events are not part of the everyday system. Ms Stocking agreed that the consumer's view is of value, pointing out that a patient group has recently been involved in a national plan on kidney treatment.
Another question pursued the topic of when to evaluate, and when and how to disseminate information, problems arising over the value of fetal heart monitoring being given as an example. Dr Bos replied with another problem: we know that heart transplants can be successful but there are not enough donors and 50% of patients may die on the waiting list. He argued that we should consult consumers and cardiologists on such matters. Ms Stocking agreed, but pointed out that certain people in every profession are opinion leaders; they are the keys to effective diffusion.
There followed a discussion on the range of technologies to be evaluated: should we concentrate on the new or should we look also at the old? Holland aims to evaluate existing technologies as well as the Journal of the Royal Society of Medicine Volume 82 September 1989 569 new but the real problem with conclusions on what is already being done is that it is very difficult to get people to change their practice.
A more precise question came on the introduction of the CT scan, originally justified on the grounds that this would involve fewer invasive techniques for the examination of the brain. In fact the main result of the CT and the NMR scans is more rather than less, since the new is simply added on to the old. Dr Bos noted that doctors in Holland wanted more CT scans and in response to demands evaluated and financed them from within their budgets.
Another specific question came on the way that national schemes for screening for breast cancer get going. A member of the audience, from the Department of Health, said that in Britain their cost effectiveness was based on studies carried out overseas. Dr Bos remarked that many people were sceptical about the value of such programmes because they cause so much anxiety. Monitoring is essential.
Towards the end of the evening a further general question was put: how do we balance the needs of the individual with those of the nation? Dr Maxwell cited the lone yachtsman phenomenon: if one man is stranded at sea we will mobilize any amount of resources to undertake a rescue. Perhaps the answer is to look at a number of different factors, for example the medical treatment of heart disease touches only a minority.
In conclusion, Dr Maxwell tried his own bit of prediction, saying that when we look back on the present in ten years' time we will be amazed at how primitive we are. There was no disagreement.
Richard Lansdown
Editorial Representative, Open Section (Accepted 9 June 1989)
Developing abnormally
Keywords: monochorionic; embryonic growth factors; morphogen; placenta; mono-and dizygotic twins A joint meeting was held by the Section of Comparative Medicine with the Sections of Obstetrics and Gynaecology, and Pathology, the Developmental Pathology Society and the Blair Bell Research Society. The occasion was the presentation of the Burroughs Wellcome Travelling Fellowship lecture by Professor K Benirschke (California). The first two speakers were concerned with factors controlling normal development as observed in animal studies, and the other two speakers described abnormal development of the fetus from a human point of view.
The first speaker, Professor L Wolpert (University College and Middlesex School of Medicine), gave an account of present understanding of the forces which control morphogenesis in the embryo. He used the developing chick limb as a model to demonstrate the pattern of development from undifferentiated cells. It is established that cells differentiate according to their spatial position and not as a result of autonomous differentiation at cell division. One way in which cells in the limb bud develop different positional identity is believed to depend on the chemical gradient across the limb bud of a morphogen released from a specific area (polarizing zone) on the posterior surface of the limb bud. Research has shown that grafting this area to the anterior surface of another limb bud can induce mirror image duplication of the whole limb and that irradiation of the polarizing area attenuates this effect. Interspecies grafting of the polarizing region results in development of the morphology of the donor. There is strong evidence that the morphogen may be retinoic acid (vitamin A), since this compound induces the same effects.
However, this hypothesis is inadequate to explain developmental differentiation completely, since dissociated tissue, repacked into the ectodermal jacket so that there is no polarizing zone, still develops into digit-like elements.
There is also a mechanism which dictates development of cartilage on the proximal/distal axis. This could depend on relative diffusion of an 'activator' and 'deactivator' along this axis.
Professor Wolpert commented that there is no evidence that abnormalities in development represent misinterpretation of positional signals, but most probably results from alterations in the blood supply which cause cell degeneration. Fusion of digits is apparently caused by abnormal narrowness of the limb bud, but positional development is normal.
He concluded by saying that growth hormones are not important in morphological development since individual growth plates contain intrinsic patterns of growth, which dictate the future growth profile of the whole element.
The theme of growth factors was expanded by the second speaker, Professor F Beck (University of Leicester Medical School). He described an in vitro method used to investigate the relative contribution of maternal and fetal growth factors to early embryonic growth and development. The method involves removing the embryo from the decidual mass of the rat uterus soon after implantation (9 days gestation). The embryo can then be maintained in culture for 48 hours and under optimal conditions normal growth occurs. This growth depends on factors in maternal serum since at least 10% autologous serum is required for normal growth, and repeated use of the serum depletes its ability to support growth. Manipulation of insulin levels has shown that all growth parameters are dependent on its presence in the bathing serum. It appears that maternal insulin is important for normal fetal growth and development until 14/15 days gestation, when fetal production of growth factors develops. Embryopathic effects in diabetics probably relate to insulin deficiency rather than ketosis. Insulin receptors have been identified on the yolk sac, but actual transfer has not been demonstrated.
The relative levels of maternal and fetal growth factors in tissues at different stages in embryonic development can be measured by quantifying specific mRNA using a Northern blot. Two separate somatomedins have been identified, IGF 1 in adult tissue and IGF2 in fetal and yolk sac tissue. IGF 1 is only produced after birth, reaching a high level in the liver by 20 days. IGF 2 is found in fetal liver, skeletal muscle/cartilage and the choroid plexus, and it disappears at different rates from these tissues after birth -from the liver by 18/20 days and from the muscle after 23 days, but it persists in the choroid plexus until adulthood. The switch coincides with the surge in glucocorticoid production, which normally occurs at 20 days (the time of weaning), and treatment of neonates (9 days) with cortisone induces the same graded extinction of IGF2 at this age as that seen physiologically after weaning. Receptor sites for IGF 2 in fetal tissues have been probed and found to correlate with areas of IGF 2 production, with the exception of the heart, where the receptors identified probably bind IGF 2 released from the liver.
A review of developmental abnormalities in man by Professor E A1berman <London Hospital Medical College) divided abnormalities into (1)fetallosslearly death; (ii) growth disturbance; and (iii) impairment, which could be of no consequence or which might lead to disability and, in some cases, subsequent handicap. Causes of abnormal development could be divided into genetic, chromosomal, developmental growth disturbances, teratogenesis, and multifactorial conditions or curtailed gestation. It was often difficult to establish causes of premature death or abortion.
Development ofthe conceptus to the four-week postpartum phase under normal circumstances exhibited an 8% loss or mortality. This figure was markedly increased in chromosomal disorders. The role of placental insufficiency in determining maternal (but not paternal) size correlation between mothers and daughters was discussed. Growth factors were considered to be a possible aetiological factor. Teratogenic effectsof drugs, viruses and other agents were reviewed.
The contribution of the twinning process to an understanding of abnormalities was lucidly reviewed by Professor Kurt Bernirschke (Burroughs Wellcome Visiting Professor, University of California San Diego Medical School, USA). Important distinctions in monozygotic and dizygotic twinning processes were highlighted. Dizygotic twinning increased with parental age and showed remarkable racial variation from 3.85x1O-3 in Asians, 7.9x10-3 in Europeans, up to 44.5x10-3 in Yoruba tribespeople in Africa. In contrast, monozygotic twinning shows no age-related effects nor racial variations in the 4.0x10-3 incidence.
Dizygotic twins were associated with elevated pituitary FSH and LH plasma levels -oestradiol concentrations were not correlated.
Monozygotic quadruplets are normal in the ninebanded armadillo in which a single blastocyst implants and then four poles separate to produce four male or four female offspring. This process has never been shown to cause birth defects by incomplete separation.
Conjoined twins in man (and whales) are always monozygotic and the fusion theory could be discounted. The importance of placental examination was emphasized in twin births. Monochorionic placentas, whether mono-or di-amniotic, were found only with monozygotic twins, whereas diamniotic/dochorionic placentas could be found in monozygotic and dizygotic twinning. The spectrum of twinning from dichorionic/ diamniotic twins, where separation occurred up to day 3, to conjoined twins and formation of sacrococcygeal appendages sharing amniotic, chorionic and yolk sac spaces were correlated with the stages of embryogenesis during which separation took place. Conditions resulting from vascular anastomoses between twins, such as chimaerism in marmosets, and freemartin calves, were discussed. Cardiovascular shunting with cardiac and haematological perturbations and death with injury to the remaining fetus in the form of disseminated intravascular coagulation (twin transfusion syndrome) and 'aplasia cutis' were described in man.
